Yes. There is an article at http://www.polymyositisresearch.org/articles/11 that suggests this type of virus can be neutralized without side effects by Lauricidin, a substance obtained from coconut. No side effects.

Knowing my post is not connected to the initial question but:

Information added with regard to actuality (hass been reported today in Austrian Newspaper for the first time):

MEYER SAUTEUR PM et al:

Research Article

Mycoplasma pneumoniae triggering the Guillain-Barré syndrome: A case-control study

Annals of Neurology, Volume 80, Issue 4 October 2016

Pages 566–580

First published: 26 August 2016   

DOI: 10.1002/ana.24755

http://onlinelibrary.wiley.com/doi/10.1002/ana.24755/abstract

For convenience only:

Abstract

Objective

Guillain-Barré syndrome (GBS) is an acute postinfectious immune-mediated polyneuropathy. Although preceding respiratory tract infections with Mycoplasma pneumoniae have been reported in some cases, the role of M. pneumoniae in the pathogenesis of GBS remains unclear. We here cultured, for the first time, M. pneumoniae from a GBS patient with antibodies against galactocerebroside (GalC), which cross-reacted with the isolate. This case prompted us to unravel the role of M. pneumoniae in GBS in a case-control study.

Methods

We included 189 adults and 24 children with GBS and compared them to control cohorts for analysis of serum antibodies against M. pneumoniae (n = 479) and GalC (n = 198).

Results

Anti–M. pneumoniae immunoglobulin (Ig) M antibodies were detected in GBS patients and healthy controls in 3% and 0% of adults (p = 0.16) and 21% and 7% of children (p = 0.03), respectively. Anti-GalC antibodies (IgM and/or IgG) were found in 4% of adults and 25% of children with GBS (p = 0.001). Anti-GalC-positive patients showed more-frequent preceding respiratory symptoms, cranial nerve involvement, and a better outcome. Anti-GalC antibodies correlated with anti–M. pneumoniae antibodies (p < 0.001) and cross-reacted with different M. pneumoniae strains. Anti-GalC IgM antibodies were not only found in GBS patients with M. pneumoniae infection, but also in patients without neurological disease (8% vs 9%; p = 0.87), whereas anti-GalC IgG was exclusively found in patients with GBS (9% vs 0%; p = 0.006).

Interpretation

M. pneumoniae infection is associated with GBS, more frequently in children than adults, and elicits anti-GalC antibodies, of which specifically anti-GalC IgG may contribute to the pathogenesis of GBS. Ann Neurol 2016;80:566–580

Dear Dr. Victor Christianto

Guillain-Barre syndrome (GBS) is a serious and rare autoimmune disorder in which the immune system of the body attacks healthy nerve cells of the peripheral nervous system. Exact cause of the syndrome is not properly understood. However, it is certainly not inheritable.

Is there cure for Guillain-Barre Syndrome (GBS)?

Yes. Please have a look at these RG links and PDF attachments.

Article An ayurvedic approach in the management of Guillain-Barre Sy...

Article Author response: Successful treatment of Guillain–Barre synd...

Article Successful treatment of Guillain–Barre syndrome by Ayurvedic treatment

Article Treatment guidelines for Guillain–Barré Syndrome

Thanks!